SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

COAR is a community-driven meme token on the Solana blockchain built around the theme of oil and energy. The project brings together a growing community of crypto enthusiasts who share an interest in energy-themed digital assets. COAR operates as a fully decentralized token with active trading on Solana decentralized exchanges. The token has a fixed maximum supply of 1 billion units with 6 decimal places, and its mint authority has been permanently revoked, making the supply immutable. The project features a dedicated website at coargov.com with real-time market data integration via DexScreener.

Chinese Oil Asset Reserve

COAR is gaining momentum as investors rally around its unconventional blend of oil tokenization, geopolitical themes, and viral social media narratives. Community members are actively debating the project's unique positioning and its potential to capture attention through highly speculative, meme-driven marketing.

Invesco Exchange-Traded Fund Trust II - Invesco S&P 500 Momentum ETF

Invesco S&P 500 Momentum ETF

The Invesco S&P 500 Momentum ETF is trending as investors debate its role as a core portfolio holding, frequently highlighting its historical tendency to outperform traditional S&P 500 benchmarks over longer periods. Community discussions center on the pros and cons of its semi-annual rebalancing strategy, with some users favoring it as a "set it and forget it" momentum play, while others weigh it against more actively managed or frequently rotating alternatives.

Bill Holdings, Inc. engages in the provision of cloud-based software solutions. The firm simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses. Its software helps customers generate and process invoices, streamline approvals, send and receive payments, sync with their accounting systems and manage their cash. The company was founded by Rene Lacertea in April 2006 and is headquartered in San Jose, CA.

BILL Holdings Inc

Bill.com Holdings Inc

Bill.com Holdings is trending due to persistent speculation regarding a potential buyout, bolstered by active interest from activist investors like Starboard Value and Elliott Investment Management. The community remains heavily divided, with many traders holding for a premium acquisition while others express frustration over the stock's stagnant performance and valuation pressure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting significant community attention as a key player in the decentralized perpetual exchange sector, with investors closely watching its high transaction volume and potential for market share expansion. The broader conversation is heavily influenced by its integration into institutional portfolios, upcoming token unlock schedules, and its ongoing role as a preferred venue for trading during periods of high geopolitical and market volatility.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as retail investors capitalize on high-volatility price swings within the biotech sector, heavily influenced by leveraged trading strategies and ongoing community speculation regarding potential buyouts and FDA-related catalysts. Sentiment remains polarized between traders betting on sustained sector momentum driven by AI-led drug discovery and those anticipating a sharp mean reversion as leveraged decay impacts long-term holdings.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is trending as investors capitalize on its deep ties to the Hyperliquid ecosystem and the strong performance of its HYPE token treasury. The community is actively debating the stock's role as a high-beta infrastructure proxy while navigating ongoing questions about NAV discounts and potential rotation from crypto-adjacent assets.

Waste Management, Inc. is a holding company, which engages in the provision of waste management environmental services. It operates through the following segments: Collection and Disposal-East Tier (East Tier), Collection and Disposal-West Tier (West Tier), Recycling Processing and Sales, Renewable Energy, and Healthcare Solutions. The East Tier segment includes the Eastern United States, the Great Lakes Region, and Canada. The West Tier segment refers to the upper Midwest region and British Columbia, Canada. The Recycling Processing and Sales segment focuses on the processing and sales of materials collected from residential, commercial, and industrial customers. The Renewable Energy segment develops, operates, and promotes projects for landfill gas use. The Healthcare Solutions segment relates to its primarily business to business company providing services that protect people and brands, promote health and well-being and safeguard the environment. The company was founded on September 30, 1987 and is headquartered in Houston, TX.

Waste Management, Inc.

Waste Management is attracting significant investor attention as a defensive "Steady Eddie" play amid broader market volatility, with community discussions centering on its essential service model, consistent dividend growth, and potential for margin expansion through AI integration and renewable natural gas. Investors are particularly focused on the stock's resilience during economic uncertainty, often comparing its stability to cyclical sectors while monitoring recent management efforts to optimize costs and operations.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

The community is actively debating the future of the biotechnology sector, with many investors closely monitoring XBI technical levels as a primary catalyst for trading the leveraged LABD ETF. Sentiment remains divided between those positioning for a potential sector reversal and those frustrated by continued bullish strength in biotech assets.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending as investors monitor its position in the semiconductor cycle following a series of analyst upgrades and active discussions about whether the stock represents a defensive play or a value-driven growth opportunity. The community is focused on the balance between recent price momentum, its role in AI infrastructure, and the potential for a broader rebound in the industrial and automotive chip segments.

Star Bulk Carriers Corp. is a global shipping company, which engages in the provision of seaborne transportation solutions in the dry bulk sector. The firm's vessels transport major bulks, which include iron ore, minerals and grain, and minor bulks, which include bauxite, fertilizers and steel products. The company was founded by Petros Alexandros Pappas on December 13, 2006 and is headquartered in Athens, Greece.

Star Bulk Carriers Corp

Star Bulk Carriers is trending as investors weigh the company's strong earnings momentum and aggressive dividend increases against volatility in the dry bulk shipping sector. The community is actively discussing the stock's potential for further upside as they analyze recent performance, management's capital allocation strategy, and the broader impact of global trade logistics on freight rates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of +93.35% and +16.63%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results PR Newswire...

Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for PTC Therapeutics (PTCT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.

Horizon Investments LLC Takes $3.06 Million Position in PTC Therapeutics, Inc. $PTCT

Horizon Investments LLC acquired a new stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 40,333 shares of the biopharmaceutical company's stock, va...

Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Agenus (AGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTC Therapeutics to Participate in Upcoming Investor Conferences PTC Therapeutics to Participate in Upcoming Investor Conferences PR Newswire WARREN, N.J., May 4, 2026 WARREN, N.J., May 4, 2026...

Vanguard Group Inc. Purchases 514,204 Shares of PTC Therapeutics, Inc. $PTCT

Vanguard Group Inc. raised its position in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 6.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,803,203 shares of th...

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PTC Therapeutics (PTCT) Expected to Announce Earnings on Thursday

PTC Therapeutics (NASDAQ:PTCT) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

PTCT
PTC Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest PTCT News

PTCTPTC Therapeutics Inc